Neuroone Medical Technologies Corp (NMTC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket
 


Neuroone Medical Technologies Corp  (NASDAQ: NMTC)


Neuroone Medical Technologies's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neuroone Medical Technologies's ROI in the second quarter of 2026?
Neuroone Medical Technologies Corp recorded a cumulative net loss of $-7 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -81.68%.

Within the Healthcare sector 623 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 3965, from total ROI ranking in the first quarter of 2025 at 4691.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2026)
II. Quarter
(Dec 31 2025)
I. Quarter
(Sep 30 2025)
IV. Quarter
(Jun 30 2025)
III. Quarter
(Mar 31 2025)
II. Quarter
Y / Y Investment Change TTM 151.69 % 75.67 % 20.53 % -9.81 % -41.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 8 8 9 3
Return On Investment (TTM) -81.68 % -94.02 % -60.78 % -102.98 % -189.01 %
NMTC's Overall Ranking # 3965 # 4691 # 3945 # 4222 # 4459
Seq. Investment Change TTM 11.99 % 22.45 % 28.49 % 42.85 % -21.84 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -7 -7 -4 -5 -6




Return On Investment NMTC's Ranking
Within: No.
Industry # 145
Sector # 624
Overall # 3965

Return On Investment Statistics
High Average Low
-60.78 %
-137.42 %
-250.15 %
(Sep 30 2025)   (Mar 31 2024)







Financial Statements
Neuroone Medical Technologies's II. Quarter Investments $ 6 Millions NMTC's Balance sheet
Neuroone Medical Technologies's II. Quarter Income $ -2 Millions Quarterly NMTC's Income Statement
NMTC's Income by Division See NMTC's Income by Division


NMTC Annual Return On Investment (Sep 30 2025)
2025
(Sep 30 2023)
2023
(Sep 30 2022)
2022
(Sep 30 2021)
2021
(Jul 31 2015)
2015
Total Investments in Millions 8 6 10 7 0
Y / Y Investment Growth 34.54 % -35.16 % 43.91 % - -
Net Income in Millions -4 -12 -10 -10 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -42.5 % -188.11 % -102.84 % -147.23 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NMTC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NMTC's Competitors
Subscribers only: Roi for Neuroone Medical Technologies's Suppliers
Subscribers only: Return On Investment for NMTC's Customers

Other Ratios
NMTC's Roa NMTC's Inventory Turnover Ratio NMTC's Growth Rates NMTC's Dividend Statistics
NMTC's Profitability Ratios NMTC's Asset Turnover Ratio NMTC's Dividend Growth
NMTC's Roe NMTC's Valuation Ratios NMTC's Financial Strength Ratios NMTC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI


Date modified: 2026-09-18T10:53:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.